Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats [Retraction]

J Inflamm Res. 2022 Nov 7:15:6069-6070. doi: 10.2147/JIR.S395887. eCollection 2022.

Abstract

[This retracts the article DOI: 10.2147/JIR.S284471.].

Publication types

  • Retraction Notice